PATENT CLAIM ANALYSIS

Application Number: 15883271
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "464000"]

Abstract:
The invention relates to a monolithic pharmaceutical dosage form comprising a hot melt-extruded first segment (S 1 ) and a second segment (S 2 ); wherein the first segment (S 1 ) contains at least a first pharmacologically active ingredient (A 1 ) and/or the second segment (S 2 ) contains at least a second pharmacologically active ingredient (A 2 ); and the segment (S 1 ) and/or the segment (S 2 ) is tamper-resistant and/or exhibits a breaking strength of at least 300 N.

Claim (Index 9):
The monolithic pharmaceutical dosage form according to  claim 1 , wherein the segment (S 1 ) and/or the segment (S 2 ) which is tamper-resistant and/or exhibits a breaking strength of at least 300 N provides resistance against grinding and/or resistance against solvent extraction and/or resistance against dose-dumping in aqueous ethanol.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 86.0
- Lexical Diversity: 2.34146
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14287348', '13864450', '14287512', '14327671', '14979888']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7453114080841415
- 35 USC 102 Novelty (BERT): 0.5233177859543875
- Combined Prediction Score: 0.7231120458711662
- Mean Citation Score: 313.37790000000007
- Max Citation Score: 341.29034
- Similarity Product: 277.3069654380716

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test